Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fibroblast growth factor 7 pseudogene 8 (FGF7P8) is a human pseudogene located on chromosome 16. It is derived from duplication or retrotransposition events of the functional FGF7 gene. Like most pseudogenes, FGF7P8 is considered nonfunctional in terms of encoding a protein; pseudogenes do not produce proteins and are generally regarded as genomic relics. Nonetheless, some pseudogenes can be transcribed and exert regulatory roles via RNA, including acting as decoys for microRNAs or generating short interfering RNAs, but there is currently no reported biological or clinical significance for FGF7P8 specifically. It is not used as a therapeutic target, is not known to participate in disease processes, and does not interact with any drugs.
None. No mechanisms of action are applicable since this is not a functional protein or therapeutic target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fibroblast growth factor 7 pseudogene 8 (FGF7P8).